Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sivextro in Prosthetic Joint Infections
NCT03746327Phase 4Completed
- Sponsor
- Fundació Clínic per a la Recerca Biomèdica
- Start
- Feb 2020
- Primary completion
- Jan 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of tedizolid in prosthetic joint infection (PJI), sponsored by Fundació Clínic per a la Recerca Biomèdica. Started Feb 2020; status: completed.
02
Drugs
tedizolid
03
Conditions
prosthetic joint infection (PJI)
Beyond the preview
Go deeper on NCT03746327.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03746327.